VOYA INVESTMENT MANAGEMENT LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1068837
ATLANTA, GA
Position in CATX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$481,588
+$452,232 QoQ
Shares Held
115,489
+981.9% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $368,850,822 across 50 Medical Devices names. CATX ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
455,560 | $95,594,709 | |
| 2 | MDT |
Medtronic plc
|
709,994 | $61,520,979 | |
| 3 | ABT |
Abbott Laboratories
|
408,127 | $41,902,398 | |
| 4 | STE |
STERIS plc
|
149,409 | $33,038,812 | |
| 5 | BSX |
Boston Scientific Corp
|
422,418 | $26,506,728 | |
| 6 | SYK |
Stryker Corp
|
74,872 | $24,602,189 | |
| 7 | TNDM |
Tandem Diabetes Care Inc
|
804,137 | $15,415,305 | |
| 8 | PEN |
Penumbra Inc
|
33,907 | $11,134,041 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $481,588 | 115,489 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $29,356 | 10,675 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $36,615 | 10,675 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $56,918 | 16,546 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $32,838 | 15,417 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $51,974 | 16,293 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $228,351 | 17,105 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $158,213 | 15,869 | Shares | Defined | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||